Skip to main content

MoneyWorks4Me

Tatva Chintan Pharma - Quaterly Results

20 Oct 2026 Evaluate
The topline surged 79.08% to Rs. 2074.84 millions for the September 2026 quarter as against Rs. 1158.63 millions during the corresponding quarter last year.Profit for the quarter ended September 2026 rises by 72.09% to Rs. 153.87  millions from Rs. 89.41 millions.OP of the company witnessed a marginal growth to 339.38 millions from 219.03 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 2074.84 1158.63 79.08 3541.86 2250.43 57.39 4962.96 3664.15 35.45
Other Income 27.05 7.94 240.68 67.38 21.63 211.51 35.28 35.61 -0.93
PBIDT 339.38 219.03 54.95 619.96 383.39 61.70 928.58 294.05 215.79
Interest 27.09 5.07 434.32 47.90 9.20 420.65 28.51 12.90 121.01
PBDT 312.29 213.96 45.96 558.88 374.19 49.36 900.07 281.15 220.14
Depreciation 107.92 90.53 19.21 213.57 180.22 18.51 368.42 276.54 33.22
PBT 204.37 123.43 65.58 345.31 193.97 78.02 531.65 4.61 11432.54
TAX 50.50 34.02 48.44 86.98 53.23 63.40 140.83 1.34 10409.70
Deferred Tax 32.81 12.59 160.60 69.29 19.68 252.08 40.16 1.32 2942.42
PAT 153.87 89.41 72.09 258.33 140.74 83.55 390.82 3.27 11851.68
Equity 233.92 233.92 0.00 233.92 233.92 0.00 233.92 233.92 0.00
PBIDTM(%) 16.36 18.90 -13.47 17.50 17.04 2.74 18.71 8.03 133.15
Peers
Company Name CMP
Godrej Industries 929.55
SRF 2354.95
BASF India 3165.45
Pidilite Inds. 1421.40
Tata Chemicals 602.60
View more..